Report cover image

Pharmacogenomics Services Market - A Global and Regional Analysis: Focus on Service, Technology, Application, End User, and Country-Wise Analysis - Analysis and Forecast, 2021-2031

Publisher BIS Research
Published Jan 07, 2022
Length 234 Pages
SKU # BIS16906025

Description

Pharmacogenomics Services Market - A Global and Regional Analysis: Focus on Service, Technology, Application, End User, and Country-Wise Analysis - Analysis and Forecast, 2021-2031

Market Report Coverage - Pharmacogenomics Services

Market Segmentation
  • Service - Genotyping, SNP Identification, Pharmacogenetic Testing, and Other Services
  • Technology - Polymerase Chain Reaction (PCR), Microarray, Sequencing, and Other Technologies
  • Application - Oncology, Infectious Disease, Neurology/Psychiatry, Cardiovascular, and Other Applications
  • End User - Research Organizations, Pharmaceutical Companies, Diagnostic Centers, and Other End Users
Regional Segmentation
  • North America - U.S. and Canada
  • Europe - Germany, U.K., France, Italy, Spain, Demark, Netherlands, and Rest-of-Europe
  • Asia-Pacific - Japan, China, Australia, India, Singapore, and Rest-of-Asia-Pacific
  • Latin America - Brazil, Mexico, and Rest-of-Latin America
  • Rest-of-the-World
Market Growth Drivers
  • Increasing Prevalence of Infectious Diseases and Various Types of Cancer Globally
  • Increase in Adoption of Personalized Medicine Shifting the Paradigm from Reaction to Prevention on a Global Level
  • Increasing Rate of Adverse Drug Reaction
  • Surge in Usage of Pharmacogenomics for Drug Discovery and Development
Market Challenges
  • Lack of Use of Available Data for Drug Development Initiatives
  • Lack of High Complexity Testing Centers
  • Difficulties in Detecting Gene Variation Affecting Drug Response
  • Regulatory Challenges for Direct-to-Consumer (DTC) Pharmacogenomics Companies
Market Opportunities
  • Massive Scope for Adoption of Pharmacogenomics in Emerging Nations
  • Technological Advancements in Molecular Techniques for Pharmacogenomic Diagnostic Tests
  • Rise of Direct-to-Consumer (DTC) Testing Services
Key Companies Profiled

Abbott Laboratories, Admera Health, LLC, Mesa Laboratories, Inc., Dynamic DNA Laboratories, F. Hoffmann-La Roche Ltd., geneOmbio Technologies Pvt Ltd., Exact Sciences Corporation, Illumina, Inc., Laboratory Corporation of America Holdings, Myriad Genetics, Inc., OmeCare, QIAGEN N.V., Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc., Precipio, 23andMe, Inc., OneOme, LLC, DiaCarta, Inc., OPKO Health

Key Questions Answered in this Report:
  • How are pharmacogenomics services revolutionizing clinical diagnostics and translational research?
  • What are the major market drivers, challenges, and opportunities in the global pharmacogenomics services market?
  • What are the underlying structures resulting in the emerging trends within the global pharmacogenomics services market?
  • How did the COVID-19 pandemic impact the global pharmacogenomics services ecosystem?
  • What are key development strategies that are being implemented by the major players in order to sustain themselves in the competitive market?
  • What are the key regulatory implications in developed and developing regions pertaining to the use of pharmacogenomics services?
  • What are the potential entry barriers expected to be faced by the companies willing to enter a particular region?
  • How is each segment of the market expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each of the segments? Following are the segments:
  • Service (genotyping, SNP identification, pharmacogenetic testing, and other services)
  • Technology (polymerase chain reaction, microarray, sequencing, and other technologies)
  • Application (oncology, infectious disease, neurology/psychiatry, cardiovascular, and other applications)
  • End user (research organizations, pharmaceutical companies, diagnostic centers, and other end users)
  • Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)
  • What are the growth opportunities for the pharmacogenomics services companies in the region of their operation?
  • Who are the leading players with significant offerings in the global pharmacogenomics services market?
  • Which companies are anticipated to be highly disruptive in the future, and why?
Market Overview

Our healthcare experts have found the pharmacogenomics services industry to be one of the most rapidly evolving and dynamic markets. The global pharmacogenomics services market is projected to reach $9,346.8 million by 2031 from $5,060.0 million in 2020, at a CAGR of 5.71% during the forecast period 2021-2031. The market is driven by certain factors, including increasing prevalence of infectious diseases and various types of cancer, increasing adoption of personalized medicine shifting the paradigm from reaction to prevention, increasing rate of adverse drug reaction, and surge in usage of pharmacogenomics for drug discovery and development.

Currently, the pharmacogenomics services industry is witnessing an upsurge due to the increasing prevalence of infectious diseases and various types of cancer, increase in adoption of personalized medicine shifting the paradigm from reaction to prevention, increasing rate of adverse drug reaction, and surge in usage of pharmacogenomics for drug discovery and development. Furthermore, companies focus on developing pharmacogenomic tests based on advanced molecular assay technologies, which is expected to further support physicians in offering better informed clinical decisions. The development of advanced pharmacogenomic tests also enables the research community to establish effective strategies for discovering novel biomarkers associated with various diseases, which could be harnessed to develop targeted therapies.

Within the research report, the market is segmented on the basis of service, technology, application, end user, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The exponential rise in the prevalence associated with cancer, infectious diseases, and cardiovascular diseases, worldwide has created a buzz among the biotechnology companies to further invest in developing novel pharmacogenomic tests based on molecular technologies for supporting physicians to offer precision care. Due to the expansive service portfolio and massive global presence, Laboratory Corporation of America Holdings has been the leading player in the pharmacogenomics services ecosystem.

On the basis of region, North America holds the largest share of the pharmacogenomics services market due to the presence of market leaders such as Laboratory Corporation of America Holdings, Illumina, Inc., Thermo Fisher Scientific Inc., and Quest Diagnostics Incorporated in the U.S., coupled with the significant adoption of high-fidelity pharmacogenomic tests for drug discovery and biomarker research. Further, rising fund infusions by the federal organizations coupled with increasing investments for pharmacogenomics development are some of the prominent underlying factors supporting the growth of the North America pharmacogenomics services market. Apart from this, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period 2021-2031. This is majorly attributed to the underlying factors such as an increase in healthcare awareness, a steady economy leading to a higher focus on research, and the growth in the adoption of pharmacogenomic tests, among others.

*PDF email from publisher allows for 1-3 users, with permission to print*

Table of Contents

234 Pages
1 Market
1.1 Global Market Outlook
1.1.1 Product Definition
1.1.2 Inclusion and Exclusion Criteria
1.1.3 Key Findings
1.1.4 Assumptions and Limitations
1.1.5 Global Market Scenario
1.1.5.1 Realistic Scenario
1.1.5.2 Optimistic Scenario
1.1.5.3 Pessimistic Scenario
1.2 Industry Outlook
1.2.1 Technology Landscape
1.2.1.1 Key Trends
1.2.1.2 Opportunity Assessment
1.2.1.2.1 Short-Term Potential
1.2.1.2.2 Long-Term Potential
1.2.2 Patent Analysis
1.2.2.1 Patent Publication Growth Trend
1.2.2.2 Patent Analysis by Country/Cluster
1.2.3 Product Benchmarking
1.2.4 Ongoing Clinical Trial Studies
1.3 Impact of COVID-19 on Global ENT Devices Market
1.3.1 Impact on Facilities
1.3.2 Impact on Device Adoption
1.3.3 Impact on Market Size
1.3.3.1 Pre-COVID-19 Phase
1.3.3.2 During COVID-19 Phase
1.3.3.3 Post-COVID-19 Phase
1.4 Procedure Volume
1.5 Market Analysis
1.5.1 Exoscopes Market
1.5.1.1 Market Size and Forecast
1.5.1.2 By Region
1.5.1.3 By Application
1.5.1.4 By ENT Procedures
1.5.2 Comparative Analysis
1.5.2.1 Headlight Market Vs. Surgical Loop Market
1.5.2.2 Endoscopic Ear Surgeries Vs. Open Surgeries
1.5.2.2.1 Procedure Volume
1.5.2.2.2 Market Size
1.6 Business Dynamics
1.6.1 Impact Analysis
1.6.2 Business Drivers
1.6.2.1 Growing Prevalence of Hearing Disorders
1.6.2.2 Growing Technology Integration in ENT Devices
1.6.2.3 Growing Preference for Minimally Invasive Procedures in ENT Specialty
1.6.3 Business Restraints
1.6.3.1 High Cost of ENT Procedures
1.6.3.2 Social Stigma Associated with Hearing Disorders
1.6.4 Business Opportunities
1.6.4.1 Emergence of Regional ENT Device Manufacturers
1.6.4.2 Synergies Between Local Healthcare Authorities and Key Medical Device Companies
2 Application
2.1 Global ENT Devices Market (by Procedure)
2.1.1 Flexible Transoral and Transnasal Procedures
2.1.1.1 Diagnosis
2.1.1.1.1 Procedure Volume
2.1.1.1.1.1 Transnasal Laryngeal Biopsies
2.1.1.1.1.2 Transnasal Injections for Vocal Cords
2.1.1.1.1.3 Transoral Flexible Diagnostic Endoscopy
2.1.1.1.2 Market Size and Forecast
2.1.1.1.2.1 Single-Use Video Endoscopes
2.1.1.1.2.2 Others
2.1.1.2 Intervention
2.1.1.2.1 Procedure Volume
2.1.1.2.1.1 Therapeutic Endoscopy of Larynx
2.1.1.2.2 Market Size and Forecast
2.1.1.2.2.1 Single-Use Video Endoscopes
2.1.1.2.2.2 Others
2.1.2 Turbinate Reduction and Endoscopic Polyp Removal
2.1.2.1 Procedure Volume
2.1.2.1.1 Turbinate Reduction
2.1.2.1.2 Endoscopic Polyp Removal
2.1.2.2 Market Size
2.1.2.2.1 Turbinate Reduction
2.1.2.2.2 Endoscopic Polyp Removal
2.1.3 Tympanostomies and Vent Tube Operations
2.1.3.1 Procedure Volume
2.1.3.2 Market Size (by Country)
2.2 Global ENT Devices Market (by End User)
2.2.1 Opportunity Assessment
2.2.2 Growth-Share Matrix
2.2.2.1 Global ENT Surgical Devices Market, Growth-Share Matrix (by End User)
2.2.2.2 Global ENT Diagnostic Devices Market, Growth Share Matrix (by End Users)
2.2.3 Hospitals
2.2.4 ENT Clinics
2.2.5 Ambulatory Centers
2.2.6 Others
3 Products
3.1 Global ENT Devices Market (by Product Type)
3.1.1 Opportunity Assessment
3.1.2 Growth Share Matrix
3.1.3 Diagnostic Devices
3.1.4 Surgical Devices
3.1.5 Hearing Aids
3.1.6 Visualization Devices
3.1.6.1 By Region
3.1.7 Surgical Shavers and Debriders
3.1.7.1 By Region
3.1.8 Others
4 Regions
4.1 North America ENT Devices Market
4.1.1 Regulatory Framework
4.1.2 Market
4.1.2.1 Key Findings and Opportunity Assessment
4.1.2.2 Business Drivers
4.1.2.3 Business Restraints
4.1.2.4 Impact Analysis
4.1.2.5 Sizing and Forecast
4.1.3 Application
4.1.3.1 North America ENT Surgical Devices Market (by End User)
4.1.3.2 North America ENT Diagnostic Devices Market (by End User)
4.1.4 Product
4.1.4.1 North America ENT Devices Market (by Product Type)
4.1.5 North America ENT Devices Market (by Country)
4.1.5.1 U.S.
4.1.5.1.1 Market
4.1.5.1.1.1 Business Restraints
4.1.5.1.1.2 Business Drivers
4.1.5.1.1.3 Sizing and Forecast Analysis
4.1.5.1.2 Application
4.1.5.1.2.1 U.S. ENT Surgical Devices Market (by End User)
4.1.5.1.2.2 U.S. ENT Diagnostic Devices Market (by End User)
4.1.5.1.3 Product
4.1.5.1.3.1 U.S. ENT Devices Market (by Product Type)
4.1.5.2 Canada
4.1.5.2.1 Market
4.1.5.2.1.1 Business Restraints
4.1.5.2.1.2 Business Drivers
4.1.5.2.1.3 Sizing and Forecast Analysis
4.1.5.2.2 Application
4.1.5.2.2.1 Canada ENT Surgical Devices Market (by End User)
4.1.5.2.2.2 Canada ENT Diagnostic Devices Market (by End User)
4.1.5.2.3 Product
4.1.5.2.3.1 Canada ENT Devices Market (by Product Type)
4.2 Europe ENT Devices Market
4.2.1 Regulatory Framework
4.2.2 Market
4.2.2.1 Key Findings and Opportunity Assessment
4.2.2.2 Business Drivers
4.2.2.3 Business Restraints
4.2.2.4 Impact Analysis
4.2.2.5 Sizing and Forecast
4.2.3 Application
4.2.3.1 Europe ENT Surgical Devices Market (by End User)
4.2.3.2 Europe ENT Diagnostic Devices Market (by End User)
4.2.4 Product
4.2.4.1 Europe ENT Devices Market (by Product Type)
4.2.5 Europe ENT Devices Market (by Country)
4.2.5.1 Germany
4.2.5.1.1 Market
4.2.5.1.1.1 Business Restraints
4.2.5.1.1.2 Business Drivers
4.2.5.1.1.3 Sizing and Forecast Analysis
4.2.5.1.2 Application
4.2.5.1.2.1 Germany ENT Surgical Devices Market (by End User)
4.2.5.1.2.2 Germany ENT Diagnostic Devices Market (by End User)
4.2.5.1.3 Product
4.2.5.1.3.1 Germany ENT Devices Market (by Product Type)
4.2.5.2 U.K.
4.2.5.2.1 Market
4.2.5.2.1.1 Business Restraints
4.2.5.2.1.2 Business Drivers
4.2.5.2.1.3 Sizing and Forecast Analysis
4.2.5.2.2 Application
4.2.5.2.2.1 U.K. ENT Surgical Devices Market (by End User)
4.2.5.2.2.2 U.K. ENT Diagnostic Devices Market (by End User)
4.2.5.2.3 Product
4.2.5.2.3.1 U.K. ENT Devices Market (by Product Type)
4.2.5.3 France
4.2.5.3.1 Market
4.2.5.3.1.1 Business Restraints
4.2.5.3.1.2 Business Drivers
4.2.5.3.1.3 Sizing and Forecast Analysis
4.2.5.3.2 Application
4.2.5.3.2.1 France ENT Surgical Devices Market (by End User)
4.2.5.3.2.2 France ENT Diagnostic Devices Market (by End User)
4.2.5.3.3 Product
4.2.5.3.3.1 France ENT Devices Market (by Product Type)
4.2.5.4 Italy
4.2.5.4.1 Market
4.2.5.4.1.1 Business Restraints
4.2.5.4.1.2 Business Drivers
4.2.5.4.1.3 Sizing and Forecast Analysis
4.2.5.4.2 Application
4.2.5.4.2.1 Italy ENT Surgical Devices Market (by End User)
4.2.5.4.2.2 Italy ENT Diagnostic Devices Market (by End User)
4.2.5.4.3 Product
4.2.5.4.3.1 Italy ENT Devices Market (by Product Type)
4.2.5.5 Rest-of-Europe
4.2.5.5.1 Market
4.2.5.5.1.1 Business Restraints
4.2.5.5.1.2 Business Drivers
4.2.5.5.1.3 Sizing and Forecast Analysis
4.2.5.5.2 Application
4.2.5.5.2.1 Rest-of-Europe ENT Surgical Devices Market (by End User)
4.2.5.5.2.2 Rest-of-Europe ENT Diagnostic Devices Market (by End User)
4.2.5.5.3 Product
4.2.5.5.3.1 Rest-of-Europe ENT Devices Market (by Product Type)
4.3 Asia-Pacific ENT Devices Market
4.3.1 Regulatory Framework
4.3.2 Market
4.3.2.1 Key Findings and Opportunity Assessment
4.3.2.2 Business Drivers
4.3.2.3 Business Restraints
4.3.2.4 Impact Analysis
4.3.2.5 Sizing and Forecast
4.3.3 Application
4.3.3.1 Asia-Pacific ENT Surgical Devices Market (by End User)
4.3.3.2 Asia-Pacific ENT Diagnostic Devices Market (by End User)
4.3.4 Product
4.3.4.1 Asia-Pacific ENT Devices Market (by Product Type)
4.3.5 Asia-Pacific ENT Devices Market (by Country)
4.3.5.1 China
4.3.5.1.1 Market
4.3.5.1.1.1 Business Restraints
4.3.5.1.1.2 Business Drivers
4.3.5.1.1.3 Sizing and Forecast Analysis
4.3.5.1.2 Application
4.3.5.1.2.1 China ENT Surgical Devices Market (by End User)
4.3.5.1.2.2 China ENT Diagnostic Devices Market (by End User)
4.3.5.1.3 Product
4.3.5.1.3.1 China ENT Devices Market (by Product Type)
4.3.5.2 Japan
4.3.5.2.1 Market
4.3.5.2.1.1 Business Restraints
4.3.5.2.1.2 Business Drivers
4.3.5.2.1.3 Sizing and Forecast Analysis
4.3.5.2.2 Application
4.3.5.2.2.1 Japan ENT Surgical Devices Market (by End User)
4.3.5.2.2.2 Japan ENT Diagnostic Devices Market (by End User)
4.3.5.2.3 Product
4.3.5.2.3.1 Japan ENT Devices Market (by Product Type)
4.3.5.3 India
4.3.5.3.1 Market
4.3.5.3.1.1 Business Restraints
4.3.5.3.1.2 Business Drivers
4.3.5.3.1.3 Sizing and Forecast Analysis
4.3.5.3.2 Application
4.3.5.3.2.1 India ENT Surgical Devices Market (by End User)
4.3.5.3.2.2 India ENT Diagnostic Devices Market (by End User)
4.3.5.3.3 Product
4.3.5.3.3.1 India ENT Devices Market (by Product Type)
4.3.5.4 Australia
4.3.5.4.1 Market
4.3.5.4.1.1 Business Restraints
4.3.5.4.1.2 Business Drivers
4.3.5.4.1.3 Sizing and Forecast Analysis
4.3.5.4.2 Application
4.3.5.4.2.1 Australia ENT Surgical Devices Market (by End User)
4.3.5.4.2.2 Australia ENT Diagnostic Devices Market (by End User)
4.3.5.4.3 Product
4.3.5.4.3.1 Australia ENT Devices Market (by Product Type)
4.3.5.5 Rest-of-Asia-Pacific
4.3.5.5.1 Market
4.3.5.5.1.1 Business Restraints
4.3.5.5.1.2 Business Drivers
4.3.5.5.1.3 Sizing and Forecast Analysis
4.3.5.5.2 Application
4.3.5.5.2.1 Rest-of-Asia-Pacific ENT Surgical Devices Market (by End User)
4.3.5.5.2.2 Rest-of-Asia-Pacific ENT Diagnostic Devices Market (by End User)
4.3.5.5.3 Product
4.3.5.5.3.1 Rest-of-Asia-Pacific ENT Devices Market (by Product Type)
4.4 Rest-of-the-World ENT Devices Market
4.4.1 Regulatory Framework
4.4.2 Market
4.4.2.1 Key Findings and Opportunity Assessment
4.4.2.2 Business Drivers
4.4.2.3 Business Restraints
4.4.2.4 Impact Analysis
4.4.2.5 Sizing and Forecast
4.4.3 Application
4.4.3.1 Rest-of-the-World ENT Surgical Devices Market (by End User)
4.4.3.2 Rest-of-the-World ENT Diagnostic Devices Market (by End User)
4.4.4 Product
4.4.4.1 Rest-of-the-World ENT Devices Market (by Product Type)
4.4.5 Rest-of-the-World ENT Devices Market (by Region)
4.4.5.1 Latin America
4.4.5.1.1 Market
4.4.5.1.1.1 Business Restraints
4.4.5.1.1.2 Business Drivers
4.4.5.1.1.3 Sizing and Forecast Analysis
4.4.5.1.2 Application
4.4.5.1.2.1 Latin America ENT Surgical Devices Market (by End User)
4.4.5.1.2.2 Latin America ENT Diagnostic Devices Market (by End User)
4.4.5.1.3 Product
4.4.5.1.3.1 Latin America ENT Devices Market (by Product Type)
4.4.5.2 Middle East and Africa
4.4.5.2.1 Market
4.4.5.2.1.1 Business Restraints
4.4.5.2.1.2 Business Drivers
4.4.5.2.1.3 Sizing and Forecast Analysis
4.4.5.2.2 Application
4.4.5.2.2.1 Middle East and Africa ENT Surgical Devices Market (by End User)
4.4.5.2.2.2 Middle East and Africa ENT Diagnostic Devices Market (by End User)
4.4.5.2.3 Product
4.4.5.2.3.1 Middle East and Africa ENT Devices Market (by Product Type)
5 Markets - Competitive Benchmarking & Company Profiles
5.1 Competitive Benchmarking and Company Profiles
5.1.1 Competitive Landscape
5.1.1.1 Key Strategies and Developments
5.1.1.1.1 New Offerings
5.1.1.1.2 Partnerships, Alliances, and Business Expansion
5.1.1.1.3 Regulatory and Legal
5.1.1.1.4 Mergers and Acquisitions
5.1.1.1.5 Funding
5.2 Company Profiles
5.2.1 Ambu A/S
5.2.1.1 Company Overview
5.2.1.2 Role of Ambu A/S in Global ENT Devices Market
5.2.1.3 Financials
5.2.1.4 Recent Developments
5.2.1.5 SWOT Analysis
5.2.2 Atos Medical Ab
5.2.2.1 Company Overview
5.2.2.2 Role of Atos Medical Ab in the Global ENT Devices Market
5.2.2.3 Financials
5.2.2.4 Recent Developments
5.2.2.5 SWOT Analysis
5.2.3 Boston Scientific Corporation
5.2.3.1 Company Overview
5.2.3.2 Role of Boston Scientific Corporation in the Global ENT Devices Market
5.2.3.3 Financials
5.2.3.4 Recent Developments
5.2.3.5 SWOT Analysis
5.2.4 Cochlear Limited
5.2.4.1 Company Overview
5.2.4.2 Role of Cochlear Limited in the Global ENT Devices Market
5.2.4.3 Financials
5.2.4.4 Recent Developments
5.2.4.5 SWOT Analysis
5.2.5 Demant A/S
5.2.5.1 Company Overview
5.2.5.2 Role of Demant A/S in Global ENT Devices Market
5.2.5.3 Financials
5.2.5.4 Recent Developments
5.2.5.5 SWOT Analysis
5.2.6 Eckert & Ziegler BEBIG AG
5.2.6.1 Company Overview
5.2.6.2 Role of Eckert & Ziegler BEBIG AG in the Global ENT Devices Market
5.2.6.3 Financials
5.2.6.4 Recent Developments
5.2.6.5 SWOT Analysis
5.2.7 HOYA Corporation
5.2.7.1 Company Overview
5.2.7.2 Role of HOYA Corporation in Global ENT Devices Market
5.2.7.3 Financials
5.2.7.4 Recent Developments
5.2.7.5 SWOT Analysis
5.2.8 Johnson & Johnson
5.2.8.1 Company Overview
5.2.8.2 Role of Johnson & Johnson in the Global ENT Devices Market
5.2.8.3 Financials
5.2.8.4 Recent Developments
5.2.8.5 SWOT Analysis
5.2.9 KARL STORZ SE & Co. KG
5.2.9.1 Company Overview
5.2.9.2 Role of KARL STORZ SE & Co. KG in Global ENT Devices Market
5.2.9.3 Recent Developments
5.2.9.4 SWOT Analysis
5.2.10 Medtronic plc
5.2.10.1 Company Overview
5.2.10.2 Role of Medtronic plc in the Global ENT Devices Market
5.2.10.3 Financials
5.2.10.4 Recent Developments
5.2.10.5 SWOT Analysis
5.2.11 Olympus Corporation
5.2.11.1 Company Overview
5.2.11.2 Role of Olympus Corporation in Global ENT Devices Market
5.2.11.3 Financials
5.2.11.4 Recent Developments
5.2.11.5 SWOT Analysis
5.2.12 Richard Wolf GmbH
5.2.12.1 Company Overview
5.2.12.2 Role of Richard Wolf GmbH in Global ENT Devices Market
5.2.12.3 SWOT Analysis
5.2.13 Smith & Nephew Plc
5.2.13.1 Company Overview
5.2.13.2 Role of Smith & Nephew Plc in Global ENT Devices Market
5.2.13.3 Financials
5.2.13.4 Recent Developments
5.2.13.5 SWOT Analysis
5.2.14 Sonova Holding AG
5.2.14.1 Company Overview
5.2.14.2 Role of Sonova Holding AG in Global ENT Devices Market
5.2.14.3 Financials
5.2.14.4 Recent Developments
5.2.14.5 SWOT Analysis
5.2.15 Stryker Corporation
5.2.15.1 Company Overview
5.2.15.2 Role of Stryker Corporation in Global ENT Devices Market
5.2.15.3 Financials
5.2.15.4 Recent Developments
5.2.15.5 SWOT Analysis
6 Research Methodology
6.1 Data Collection and Analysis
6.2 Data Sources
6.2.1 Primary Sources
6.2.2 Secondary Sources
6.3 Data Triangulation
6.4 Market Estimation
6.5 Assumptions and Limitations
List of Figures
Figure 1: Global ENT Devices Market, $Million, 2020-2030
Figure 2: Global ENT Devices Market, Industry Analysis
Figure 3: Global ENT Devices Market, Key Developments, January 2018-15th November 2021
Figure 4: Global ENT Devices Market Share Analysis (by Product), 2020 Vs. 2030
Figure 5: Global ENT Devices Market (by Region), 2020 and 2030
Figure 6: Global ENT Devices Market, Realistic Growth Scenario, $Million, 2020-2030
Figure 7: Global ENT Devices Market, Optimistic Growth Scenario, $Million, 2020-2030
Figure 8: Global ENT Devices Market, Pessimistic Growth Scenario, $Million, 2020-2030
Figure 9: Global ENT Devices Market, Short-Term Potential, $Million, 2020-2025
Figure 10: Global ENT Devices Market, Long-Term Growth, $Million, 2025-2030
Figure 11: Global ENT Devices Market, Patent Filing Trend (by Year), 2016-2021
Figure 12: Global ENT Devices Market, Patent Filing Trend (by Country/Cluster), 2016-2021
Figure 13: Global Exoscopes Market, $Million, 2020-2030
Figure 14: Global Exoscopes Market (by Region), $Million, 2020-2030
Figure 15: Global Exoscopes Market (by Application), $Million, 2020-2030
Figure 16: Global ENT Exoscopes Market (by Application), $Million, 2020-2030
Figure 17: Global Endoscopic and Visualization Market, $Million, 2020-2030
Figure 18: Global Prevalence of Hearing Loss, 2015-2019
Figure 19: Prevalence of Disabling Hearing Loss, 2018
Figure 20: Global ENT Devices Market, by Procedure
Figure 21: Diagnostic Endoscopy of Larynx Procedure Volume, 2019-2020
Figure 22: Transnasal Laryngeal Biopsies Procedure Volume, 2019-2020
Figure 23: Transnasal Injections for Vocal Cords Procedure Volume, 2019-2020
Figure 24: Transnasal Flexible Diagnostic Endoscopy Procedure Volume, 2019-2020
Figure 25: Global ENT Diagnostic Devices Market (Single-Use Video Endoscopes), $Million, 2020-2030
Figure 26: Global ENT Diagnostic Devices Market (by Others), $Million, 2020-2030
Figure 27: Therapeutic Endoscopy of Larynx Procedure Volume, 2019-2020
Figure 28: Global ENT Intervention Devices Market (Single-Use Video Endoscopes), $Million, 2020-2030
Figure 29: Global ENT Intervention Devices Market (by Others), $Million, 2020-2030
Figure 30: Turbinate Reduction Procedure Volume, 2019-2020
Figure 31: Endoscopic Polyp Removal Procedure Volume, 2019-2020
Figure 32: Global Turbinate Reduction Market, $Million, 2019-2020
Figure 33: Global Endoscopic Polyp Removal Market, $Million, 2019-2020
Figure 34: Tympanostomies and Vent Tube Operations Procedure Volume, 2019-2020
Figure 35: Tympanostomies and Vent Tube Operations Market, $Million, 2019-2020
Figure 36: Global ENT Devices Market (by End User)
Figure 37: Global ENT Surgical Devices Market, Growth Share Matrix (by End User), 2020-2030
Figure 38: Global ENT Diagnostic Devices Market, Growth Share Matrix (by End User), 2020-2030
Figure 39: Global ENT Surgical Devices Market (by Hospitals), $Million, 2020-2030
Figure 40: Global ENT Diagnostic Devices Market (by Hospitals), $Million, 2020-2030
Figure 41: Global ENT Surgical Devices Market (by ENT Clinics), $Million, 2020-2030
Figure 42: Global ENT Diagnostic Devices Market (by ENT Clinics), $Million, 2020-2030
Figure 43: Global ENT Surgical Devices Market (by Ambulatory Centers), $Million, 2020-2030
Figure 44: Global ENT Diagnostic Devices Market (by Ambulatory Centers), $Million, 2020-2030
Figure 45: Global ENT Diagnostic Devices Market (by Others), $Million, 2020-2030
Figure 46: Global ENT Devices Market Incremental Growth Opportunity (by Product Type), $Million, 2020-2030
Figure 47: Global ENT Devices Market, Growth Share Matrix (by Product Type), 2020-2030
Figure 48: Global ENT Devices Market (Diagnostic Devices), $Million, 2020-2030
Figure 49: Global ENT Devices Market (Surgical Devices), $Million, 2020-2030
Figure 50: Global ENT Devices Market (Hearing Aids), $Million, 2020-2030
Figure 51: Global ENT Devices Market (Visualization Devices), $Million, 2020-2030
Figure 52: Global ENT Visualization Devices Market (by Region), $Million, 2020-2030
Figure 53: Global ENT Devices Market (Surgical Shavers and Debriders), $Million, 2020-2030
Figure 54: Global ENT Surgical Shavers and Debriders Market (by Region), $Million, 2020-2030
Figure 55: Global ENT Devices Market (by Others), $Million, 2020-2030
Figure 56: Global ENT Devices Market (by Region), 2020 and 2030
Figure 57: North America ENT Devices Market Incremental Growth Opportunity, $Million, 2020-2030
Figure 58: North America ENT Devices Market, $Million, 2020-2030
Figure 59: North America ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 60: North America ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 61: North America ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 62: U.S. ENT Devices Market, $Million, 2020-2030
Figure 63: U.S. ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 64: U.S. ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 65: U.S. ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 66: Canada ENT Devices Market, $Million, 2020-2030
Figure 67: Canada ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 68: Canada ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 69: Canada ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 70: Europe ENT Devices Market Incremental Growth Opportunity, $Million, 2020-2030
Figure 71: Europe ENT Devices Market, $Million, 2020-2030
Figure 72: Europe ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 73: Europe ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 74: Europe ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 75: Germany ENT Devices Market, $Million, 2020-2030
Figure 76: Germany ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 77: Germany ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 78: Germany ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 79: U.K. ENT Devices Market, $Million, 2020-2030
Figure 80: U.K. ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 81: U.K. ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 82: U.K. ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 83: France ENT Devices Market, $Million, 2020-2030
Figure 84: France ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 85: France ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 86: France ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 87: Italy ENT Devices Market, $Million, 2020-2030
Figure 88: Italy ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 89: Italy ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 90: Italy ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 91: Rest-of-Europe ENT Devices Market, $Million, 2020-2030
Figure 92: Rest-of-Europe ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 93: Rest-of-Europe ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 94: Rest-of-Europe ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 95: Asia-Pacific ENT Devices Market Incremental Growth Opportunity, $Million, 2020-2030
Figure 96: Asia-Pacific ENT Devices Market, $Million, 2020-2030
Figure 97: Asia-Pacific ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 98: Asia-Pacific ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 99: Asia-Pacific ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 100: China ENT Devices Market, $Million, 2020-2030
Figure 101: China ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 102: China ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 103: China ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 104: Japan ENT Devices Market, $Million, 2020-2030
Figure 105: Japan ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 106: Japan ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 107: Japan ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 108: India ENT Devices Market, $Million, 2020-2030
Figure 109: India ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 110: India ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 111: India ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 112: Australia ENT Devices Market, $Million, 2020-2030
Figure 113: Australia ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 114: Australia ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 115: Australia ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 116: Rest-of-Asia-Pacific ENT Devices Market, $Million, 2020-2030
Figure 117: Rest-of-Asia-Pacific ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 118: Rest-of-Asia-Pacific ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 119: Rest-of-Asia-Pacific ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 120: Rest-of-the-World ENT Devices Market Incremental Growth Opportunity, $Million, 2020-2030
Figure 121: Rest-of-the-World ENT Devices Market, $Million, 2020-2030
Figure 122: Rest-of-the-World ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 123: Rest-of-the-World ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 124: Rest-of-the-World ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 125: Latin America ENT Devices Market, $Million, 2020-2030
Figure 126: Latin America ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 127: Latin America ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 128: Latin America ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 129: Middle East and Africa ENT Devices Market, $Million, 2020-2030
Figure 130: Middle East and Africa ENT Surgical Devices Market (by End User), $Million, 2020-2030
Figure 131: Middle East and Africa ENT Diagnostic Devices Market (by End User), $Million, 2020-2030
Figure 132: Middle East and Africa ENT Devices Market (by Product Type), $Million, 2020-2030
Figure 133: Share of Key Developments and Strategies, January 2018-15th November 2021
Figure 134: New Offerings Share (by Company), January 2018-15th November 2021
Figure 135: Partnerships, Alliances, and Business Expansion Share (by Company), January 2018-15th November 2021
Figure 136: Regulatory and Legal Share (by Company), January 2018-15th November 2021
Figure 137: Mergers and Acquisitions Share (by Company), January 2018-15th November 2021
Figure 138: Funding Activities Share (by Company), January 2018-15th November 2021
Figure 139: Ambu A/S: Overall Product Portfolio
Figure 140: Ambu A/S: Overall Financials, $Million, 2019-2021
Figure 141: Ambu A/S: Revenue (by Business Segment), $Million, 2019-2021
Figure 142: Ambu A/S: Revenue (by Region), $Million, 2019-2021
Figure 143: Ambu A/S: R&D Expenditure, $Million, 2019-2021
Figure 144: Atos Medical Ab: Overall Product Portfolio
Figure 145: Atos Medical Ab: Overall Financials, $Million, 2018-2020
Figure 146: Atos Medical Ab: Revenue (by Business Segment), $Million, 2018-2020
Figure 147: Atos Medical Ab: Revenue (by Region), $Million, 2019-2020
Figure 148: Atos Medical Ab: Revenue (by Region), $Million, 2018
Figure 149: Atos Medical Ab: R&D Expenditure, $Million, 2018-2020
Figure 150: Boston Scientific Corporation: Overall Product Portfolio
Figure 151: Boston Scientific Corporation: Overall Financials, $Million, 2018-2020
Figure 152: Boston Scientific Corporation: Revenue (by Business Segment), $Million, 2018-2020
Figure 153: Boston Scientific Corporation: Revenue (by Region), $Million, 2018-2020
Figure 154: Boston Scientific Corporation: R&D Expenditure, $Million, 2018-2020
Figure 155: Cochlear Limited: Overall Product Portfolio
Figure 156: Cochlear Limited: Overall Financials, $Million, 2019-2021
Figure 157: Cochlear Limited: Revenue (by Business Segment), $Million, 2019-2021
Figure 158: Cochlear Limited: Revenue (by Region), $Million, 2019-2021
Figure 159: Cochlear Limited: R&D Expenditure, $Million, 2019-2021
Figure 160: Demant A/S: Overall Product Portfolio
Figure 161: Demant A/S: Overall Financials, $Million, 2018-2020
Figure 162: Demant A/S: Revenue (by Business Segment), $Million, 2018-2020
Figure 163: Demant A/S: Revenue (by Region), $Million, 2018-2020
Figure 164: Demant A/S: R&D Expenditure, $Million, 2018-2020
Figure 165: Eckert & Ziegler BEBIG AG: Overall Product Portfolio
Figure 166: Eckert & Ziegler BEBIG AG:Overall Financials, $Million, 2018-2020
Figure 167: Eckert & Ziegler BEBIG AG: Revenue (by Business Segment), $Million, 2018
Figure 168: Eckert & Ziegler BEBIG AG: Revenue (by Business Segment), $Million, 2019-2020
Figure 169: Eckert & Ziegler BEBIG AG: Revenue (by Region), $Million, 2018-2020
Figure 170: Eckert & Ziegler BEBIG AG: R&D Expenditure, $Million, 2018-2020
Figure 171: HOYA Corporation: Overall Product Portfolio
Figure 172: HOYA Corporation: Overall Financials, $Million, 2019-2021
Figure 173: HOYA Corporation: Revenue (by Business Segment), $Million, 2019-2021
Figure 174: HOYA Corporation: Revenue (by Region), $Million, 2019-2021
Figure 175: HOYA Corporation: R&D Expenditure, $Million, 2019-2021
Figure 176: Johnson & Johnson: Overall Product Portfolio
Figure 177: Johnson & Johnson: Overall Financials, $Million, 2018-2020
Figure 178: Johnson & Johnson: Revenue (by Business Segment), $Million, 2018-2020
Figure 179: Johnson & Johnson: Revenue (by Region), $Million, 2018-2020
Figure 180: Johnson & Johnson: R&D Expenditure, $Million, 2018-2020
Figure 181: KARL STORZ SE & Co. KG: Overall Product Portfolio
Figure 182: Medtronic plc: Overall Product Portfolio
Figure 183: Medtronic plc: Overall Financials, $Million, 2019-2021
Figure 184: Medtronic plc: Revenue (by Business Segment), $Million, 2019-2021
Figure 185: Medtronic plc: Revenue (by Region), $Million, 2019-2021
Figure 186: Medtronic plc: R&D Expenditure, $Million, 2019-2021
Figure 187: Olympus Corporation: Overall Product Portfolio
Figure 188: Olympus Corporation: Overall Financials, $Million, 2019-2021
Figure 189: Olympus Corporation: Revenue (by Business Segment), $Million, 2020-2021
Figure 190: Olympus Corporation: Revenue (by Business Segment), $Million, 2019
Figure 191: Olympus Corporation: Revenue (by Region), $Million, 2020-2021
Figure 192: Olympus Corporation: Revenue (by Region), $Million, 2019
Figure 193: Olympus Corporation: R&D Expenditure, $Million, 2019-2021
Figure 194: Richard Wolf GmbH: Overall Product Portfolio
Figure 195: Smith & Nephew Plc: Overall Product Portfolio
Figure 196: Smith & Nephew Plc: Overall Financials, $Million, 2018-2020
Figure 197: Smith & Nephew Plc: Revenue (by Business Segment), $Million, 2018-2020
Figure 198: Smith & Nephew Plc: Revenue (by Region), $Million, 2018-2020
Figure 199: Smith & Nephew Plc: R&D Expenditure, $Million, 2018-2020
Figure 200: Sonova Holding AG: Overall Product Portfolio
Figure 201: Sonova Holding AG: Overall Financials, $Million, 2019-2021
Figure 202: Sonova Holding AG: Revenue (by Business Segment), $Million, 2019-2021
Figure 203: Sonova Holding AG: Revenue (by Region), $Million, 2019-2021
Figure 204: Sonova Holding AG: R&D Expenditure, $Million, 2019-2021
Figure 205: Stryker Corporation: Overall Product Portfolio
Figure 206: Stryker Corporation: Overall Financials, $Million, 2018-2020
Figure 207: Stryker Corporation: Revenue (by Business Segment), $Million, 2018-2020
Figure 208: Stryker Corporation: Revenue (by Region), $Million, 2018-2020
Figure 209: Stryker Corporation: R&D Expenditure, $Million, 2018-2020
Figure 210: Global ENT Devices Market, Research Methodology
Figure 211: Primary Research
Figure 212: Secondary Research
Figure 213: Data Triangulation
Figure 214: Assumptions and Limitations
List of Tables
Table 1: Global ENT Devices Market, Impact Analysis
Table 2: Global ENT Devices Market, Inclusion Criteria
Table 3: Global ENT Devices Market, Exclusion Criteria
Table 4: Global ENT Devices Market, Key Trends
Table 5: Global ENT Devices Market, Product Benchmarking
Table 6: Global ENT Devices Market, Ongoing Clinical Trials
Table 7: Global ENT Devices Market, Key Procedure Volumes, 2016-2019
Table 8: Comparative Analysis Between Headlight Market and Surgical Loop Market
Table 9: ENT Procedures Share, by Modality, 2019
Table 10: Global ENT Devices Market, Impact Analysis
Table 11: FDA Approved/Cleared Advanced ENT Devices, 2019
Table 12: North America ENT Devices Market Regulatory Framework
Table 13: North America ENT Devices Market, Impact Analysis
Table 14: Challenges in MDR Implementation
Table 15: Europe ENT Devices Market, Impact Analysis
Table 16: Asia-Pacific ENT Devices Market Regulatory Framework
Table 17: Asia-Pacific ENT Devices Market, Impact Analysis
Table 18: Rest-of-the-World ENT Devices Market Regulatory Framework
Table 19: Rest-of-the-World ENT Devices Market, Impact Analysis

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us